![Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics | Neuropsychopharmacology Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-021-01023-4/MediaObjects/41386_2021_1023_Fig1_HTML.png)
Identifying nootropic drug targets via large-scale cognitive GWAS and transcriptomics | Neuropsychopharmacology
![Immune targets for therapeutic development in depression: towards precision medicine | Nature Reviews Drug Discovery Immune targets for therapeutic development in depression: towards precision medicine | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41573-021-00368-1/MediaObjects/41573_2021_368_Fig1_HTML.png)
Immune targets for therapeutic development in depression: towards precision medicine | Nature Reviews Drug Discovery
![What's wrong with my experiment?: The impact of hidden variables on neuropsychopharmacology research | Neuropsychopharmacology What's wrong with my experiment?: The impact of hidden variables on neuropsychopharmacology research | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-022-01309-1/MediaObjects/41386_2022_1309_Fig1_HTML.png)
What's wrong with my experiment?: The impact of hidden variables on neuropsychopharmacology research | Neuropsychopharmacology
![Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits | Nature Reviews Neurology Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-022-00635-8/MediaObjects/41582_2022_635_Fig1_HTML.png)
Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits | Nature Reviews Neurology
![Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan | Neuropsychopharmacology Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-023-01555-x/MediaObjects/41386_2023_1555_Fig1_HTML.png)
Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan | Neuropsychopharmacology
![Addiction as a brain disease revised: why it still matters, and the need for consilience | Neuropsychopharmacology Addiction as a brain disease revised: why it still matters, and the need for consilience | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-020-00950-y/MediaObjects/41386_2020_950_Fig1_HTML.png)
Addiction as a brain disease revised: why it still matters, and the need for consilience | Neuropsychopharmacology
![Cognitive and behavioural flexibility: neural mechanisms and clinical considerations | Nature Reviews Neuroscience Cognitive and behavioural flexibility: neural mechanisms and clinical considerations | Nature Reviews Neuroscience](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41583-021-00428-w/MediaObjects/41583_2021_428_Fig1_HTML.png)
Cognitive and behavioural flexibility: neural mechanisms and clinical considerations | Nature Reviews Neuroscience
![Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom | Nature Communications Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24365-5/MediaObjects/41467_2021_24365_Fig1_HTML.png)